Uncategorised - European Medical Journal

US-RASP Benefits for Large-Volume BPH Patients

US-RASP Benefits for Large-Volume BPH Patients

US-RASP has emerged as a promising alternative that maintains sexual function while providing comparable outcomes in urinary symptom relief.

Socioeconomic Gaps Worsen Survival in Young Adults with Lung Cancer

Younger adults with early-onset lung cancer face poorer survival linked to late diagnosis, income, and access to care, highlighting urgent equity needs.

Retinal Biomarkers Track Multiple Sclerosis Severity

Retinal inner layer thinning detected by OCT offers a promising biomarker for monitoring multiple sclerosis progression.

Blood Pressure: New Insights on Plasma Proteins

Blood Pressure: New Insights on Plasma Proteins

New genetic study links plasma proteins to blood pressure regulation and cardiovascular disease, offering potential targets for heart health therapies.

liver

TRIM56 is Key Driver of Liver Cancer Progression

A new study has identified TRIM56, an E3 ubiquitin ligase, as a key activator of the proto-oncogene Src in hepatocellular carcinoma.

Children playing happily after hepatitis C treatment

Pediatric Hepatitis C Fully Treated with Sofosbuvir

A recent study has demonstrated the high efficacy and favorable safety profile of sofosbuvir-based regimens in treating hepatitis C virus (HCV) in children aged 5 to 17 years.

sleep apnea concept

GLP-1 Therapy Improves Survival in Diabetes and Sleep Apnea

Patients with type 2 diabetes and obstructive sleep apnea experienced significantly greater survival benefits from GLP-1 receptor agonist therapy than those without sleep apnea.

New Study Links Systemic Sclerosis to Higher Cancer Risk

Study links systemic sclerosis to elevated cancer risks, varying by specific autoantibody profiles.

Glucocorticoid-Mediated Eosinopoiesis in Asthma Explained

Glucocorticoid-Mediated Eosinopoiesis in Asthma Explained

This paradoxical effect appears to be context-dependent, influenced by factors such as infection, allergen exposure, and systemic stress.

Concept image showing weight measurement and inflammation control in psoriatic arthritis treatment

Weight Gain Rates Stabilize After TNF Inhibitor Initiation

Tumor necrosis factor inhibitor therapy in patients with psoriatic arthritis does not appear to accelerate weight gain beyond expected age-related trends, according to findings from a retrospective cohort study.